D. Rosero

发表

Neurologic Toxicity of Immune Checkpoint Inhibitors: A Review of Literature

A. Carrato, P. Gajate, Cristina Saavedra, 2022, Frontiers in Pharmacology.

Her-2 Targeted Therapy in Advanced Urothelial Cancer: From Monoclonal Antibodies to Antibody-Drug Conjugates

J. Calvo, P. Gajate, J. Pozas, 2022, International journal of molecular sciences.

Receptor Tyrosine Kinase Inhibitors for the Treatment of Recurrent and Unresectable Bone Sarcomas

J. Calvo, J. Pozas, M. Vaz, 2022, International journal of molecular sciences.

Analysis of the Immunogenicity of mRNA-1273 SARS-CoV-2 Vaccine in Breast Cancer Patients Treated With Cyclin-Dependent Kinases 4 and 6 Inhibitors (CDKi): Limited T-Cell Immunity Despite Satisfactory Humoral Response.

A. Carrato, F. Longo, J. Casado, 2021 .

Limited T cell response to SARS-CoV-2 mRNA vaccine among patients with cancer receiving different cancer treatments

A. Carrato, F. Longo, J. Casado, 2022, European Journal of Cancer.

Outcomes and complications of S2 alar iliac fixation technique in patients with neuromuscular scoliosis: experience in a third level pediatric hospital.

F. Alvarado, J. M. Ruiz, D. Rosero, 2017, Journal of spine surgery.

Current Landscape of Immunotherapy for Advanced Sarcoma

J. Pozas, M. Vaz, Víctor Albarrán, 2023, Cancers.

Discordant Humoral and T-Cell Response to mRNA SARS-CoV-2 Vaccine and the Risk of Breakthrough Infections in Women with Breast Cancer, Receiving Cyclin-Dependent Kinase 4 and 6 Inhibitors

A. Carrato, F. Longo, J. Casado, 2023, Cancers.

Maintained complete response to talazoparib in a BRCA-2 mutated metastatic luminal breast cancer: case report and review of literature

E. Guerra, Cristina Saavedra, J. Pozas, 2023, Frontiers in Oncology.

Recurrent Glioblastoma: A Review of the Treatment Options

L. Ley, Víctor Albarrán, J. A. Gutiérrez, 2023, Cancers.

Adoptive T cell therapy for solid tumors: current landscape and future challenges

J. Pozas, Víctor Albarrán, Jesús Chamorro, 2024, Frontiers in immunology.